| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/16/1997 | EP0707465A4 Monolithic matrix transdermal delivery system |
| 04/16/1997 | EP0701551B1 3-(indol-3-yl) propenoic acid derivatives useful as nmda antagonists |
| 04/16/1997 | EP0687259B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 04/16/1997 | EP0672030B1 Process for preparing substantially pure enantiomers of phenylpropionic acids |
| 04/16/1997 | EP0669923B1 Rapamycin carbonate esters as immunosuppressant agents |
| 04/16/1997 | EP0656780B1 Drugs containing diphosphonic acids and salts thereof |
| 04/16/1997 | EP0651647B1 Glutathione as chemoprotective agent |
| 04/16/1997 | EP0619815B1 Process for the preparation of 4-methyl-5-(2-chloroethyl)-thiazole and analogues thereof |
| 04/16/1997 | EP0601001B1 Liquid food product containing 3-guanidinopropionic acid |
| 04/16/1997 | EP0586525B1 Carboxamido-(1,2n)-carbocyclic-2-aminotetralin derivatives |
| 04/16/1997 | EP0539479B1 Heterocyclic compounds |
| 04/16/1997 | EP0536282B1 Meducament for treating prostatic adenocarcinoma |
| 04/16/1997 | EP0527736B1 Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs |
| 04/16/1997 | EP0514515B1 Anthracycline-conjugates |
| 04/16/1997 | EP0502180B1 Enzymatic synthesis of oligonucleotides |
| 04/16/1997 | EP0497978B1 Cephalosporin compounds and production thereof |
| 04/16/1997 | EP0454782B1 Cancer related haptoglobin (hpr) |
| 04/16/1997 | CN1147837A Recombinant adenoviral vector and methods of use |
| 04/16/1997 | CN1147834A Coordinate in vivo gene expression |
| 04/16/1997 | CN1147815A Adenosine derivatives |
| 04/16/1997 | CN1147813A Novel selective inhibitors of viral or bacterial neuraminidases |
| 04/16/1997 | CN1147809A 0-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them |
| 04/16/1997 | CN1147768A Compositions comprising DNA damaging agents and P53 |
| 04/16/1997 | CN1147767A Use of serotonin antagonists (5HT3) for treating fibromyalgia |
| 04/16/1997 | CN1147766A Remedy for infectious diseases |
| 04/16/1997 | CN1147765A Remedy for pulmonary heart |
| 04/16/1997 | CN1147520A 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/16/1997 | CN1147519A Preparation of d4T from 5-methyluridine |
| 04/16/1997 | CN1147516A Bioavailable crystalline form of cefuroxime axetil |
| 04/16/1997 | CN1147515A Producing process for crystal of 2-oxyethyl-1-[2'-(1H-tetrazole-5-radical)diphenyl-4-(methyl)benzimidazole-7-hydroxy acid 1-(cyclohexyloxy) ethyl ester |
| 04/16/1997 | CN1147514A Thiochrome ketones as antifungal agent |
| 04/16/1997 | CN1147512A Substituted 4H-pyrans |
| 04/16/1997 | CN1147506A Benzoazepine-Benzooxaazepine-Benzothiaazepine-N-acetate derivant |
| 04/16/1997 | CN1147380A Medicine compound for gastric and duodenal ulcer |
| 04/16/1997 | CN1147379A Medicinal composite containing 2-(benzylimino)-3-benzyl-1,3-hydrothiazine and its application and prepn |
| 04/16/1997 | CN1147378A Medicinal composite of substituted 1,4,5,6-tetrahydro-diazine-[4,5-c] diazine-5-ketone compounds and its application and prepn |
| 04/16/1997 | CN1147377A Penicillin menstruum for injection |
| 04/16/1997 | CN1147376A Medicinal composite for eyes |
| 04/16/1997 | CN1147375A Multifunctional collyrium for women |
| 04/16/1997 | CN1034575C Producing process for selective adenosine receptor agents |
| 04/16/1997 | CN1034574C Process for preparing (RS)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofuranyl) acetic acids and 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzofuranyl)acetic acids and esters thereof |
| 04/16/1997 | CN1034572C Cyclic anthranilicacid acetic acid derivatives and process for prepn. |
| 04/16/1997 | CN1034571C A method for producing a pyrrolidire derivative |
| 04/16/1997 | CN1034570C Tri-lower alkoxy benzene derivatives |
| 04/16/1997 | CN1034569C Endothelin receptor antagonists |
| 04/16/1997 | CN1034552C Preparation of decahydro-isoquinoline derivatives |
| 04/16/1997 | CN1034551C New use of nicotinic acid and its derivative in preparing composition for giving up smoking |
| 04/15/1997 | US5621121 Process for the preparation of taxane derivatives |
| 04/15/1997 | US5621117 Method for the racemization of enantiomers of α-lipoic acid |
| 04/15/1997 | US5621114 Reacting a thio or phenol compound with 1,1-carbonylimidazole or 1,1-thiocarbonyldiimidazole, reacting the intermediate with secondary amine compound; useful as analgesic and memory enhancing agent |
| 04/15/1997 | US5621113 4-[(thien-2-yl)methyl]-imidazole analgesics |
| 04/15/1997 | US5621110 Amidation of an n-carboxyalkyl-2,3-dihydro-3-oxo-1,2-benzisothiazol-2-yl 1,1-dioxide with para-aminophenol |
| 04/15/1997 | US5621109 Retroviral protease inhibiting compounds |
| 04/15/1997 | US5621106 Reacting with dialkyltin oxide; acylation; alkylation |
| 04/15/1997 | US5621105 Reacting halo-substituted quinolonecarboxylic acid or naphthyridonecarboxylic acid with 1-aminomethyl-2-oxa-7-azabicyclo/3.3.0/octane |
| 04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
| 04/15/1997 | US5621101 Protein kinase inhibitors for treatment of neurological disorders |
| 04/15/1997 | US5621100 K-252a derivatives for treatment of neurological disorders |
| 04/15/1997 | US5621098 Process for preparing bis-indolyl macrocycles |
| 04/15/1997 | US5621095 Cephalosporins |
| 04/15/1997 | US5621087 Analgesics |
| 04/15/1997 | US5621012 Active compound combinations having a content of glyceryl alkyl ethers and cosmetic and dermatological formulations comprising such active compound combinations |
| 04/15/1997 | US5621011 [α-tert.butyl aminomethyl)-3,4-dichlorobenzyl] thioacetamide, a procedure for its preparation and its uses |
| 04/15/1997 | US5621009 Chondroprotective agents |
| 04/15/1997 | US5621008 N-acyl-ethylene-triacetic acids |
| 04/15/1997 | US5621007 Administering 5-trifluoromethyl-1-(5-chloro-2-hydroxyphenyl)-1,3-dehydro-2h -benzimidazol-2-one; cystic fibrosis |
| 04/15/1997 | US5621006 Topically applying in a vehicle, e.g. hydroxyacids, ketoacids and salts, esters thereof |
| 04/15/1997 | US5621005 Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives |
| 04/15/1997 | US5621004 Administering nitric oxide synthase inhibitor |
| 04/15/1997 | US5621003 Maillard reaction inhibitor |
| 04/15/1997 | US5621002 Having a modified competitive enzyme activity inhbitor linked to a spacer-drug; enzyme cleavage at a lower concentration, i.e. low michaelis-menten constant(km) |
| 04/15/1997 | US5621001 Methods for administration of taxol |
| 04/15/1997 | US5621000 Nitric esters having a pharmacological activity and process for their preparation |
| 04/15/1997 | US5620998 Cardiovascular disorders; hypotensive agents |
| 04/15/1997 | US5620997 Viricides, antiinflammatory agents, antiatherosclerotic agent |
| 04/15/1997 | US5620996 Sulfonamidocarbonyl pyridine-2-carboxesteramides and their pyridine-N-oxide compounds and their use as pharmaceuticals |
| 04/15/1997 | US5620995 Substituted heterocyclic carboxyamides, their preparation and their use as pharmaceuticals |
| 04/15/1997 | US5620993 Alpha-1a adrenergic receptor antagonists |
| 04/15/1997 | US5620992 Having 5-hydroxytryptamine receptor antagonist activity |
| 04/15/1997 | US5620991 Aromatic amidine derivatives and salts thereof |
| 04/15/1997 | US5620990 Alpha-(4-chlorophenyl)-4-[(4-fluorphenyl)-methyl]piperidine-1-ethanol esters, their preparation and their therapeutic application |
| 04/15/1997 | US5620989 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits |
| 04/15/1997 | US5620988 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| 04/15/1997 | US5620987 Amino acid derivatives |
| 04/15/1997 | US5620986 Treats benign prostatic hypertrophy, seborrhea, female hirsutism, and male and female patten baldness |
| 04/15/1997 | US5620985 Anticancer agents |
| 04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
| 04/15/1997 | US5620979 Treating neuronal loss associated with stroke, ischemia, central nervous system trauma, hypoglycemia or surgery |
| 04/15/1997 | US5620978 Nervous system disorders |
| 04/15/1997 | US5620977 Retroviral protease inhibitors |
| 04/15/1997 | US5620976 Benzoxazine derivatives |
| 04/15/1997 | US5620975 Pharmaceutical composition and method for the control of hypertension |
| 04/15/1997 | US5620970 Stable mixture containing enzyme inhibitor and (poly)ethoxylated castor oil; glaucoma, occular hypertension |
| 04/15/1997 | US5620967 Administering bis(maltolato)oxovanadium(iv) |
| 04/15/1997 | US5620966 11,21-bisphenyl-19-norpregnane derivatives |
| 04/15/1997 | US5620965 Applying to skin a mixture of salycylic acid, penetration enhancing agent, and carrier |
| 04/15/1997 | US5620964 Oligosaccharides; eliminating helicobacter from stomach |
| 04/15/1997 | US5620962 Mixed with one of contaminant selected from, chlorophyll, carotenoid, phosphatidyl choline and diacylglyceryl-n,n,n-trimethylhomoserine and a vehicle; topical dermal administeration |
| 04/15/1997 | US5620960 Inhibits segmented neutrophils |
| 04/15/1997 | US5620921 Treating keratoconjunctivitis sicca by topical application of androgen to ocular surface or immediate vicinity of eye |